Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
By offering a new strategy for weight management, GLP-1 receptor agonists hold the potential to reduce the prevalence of obesity-related complications
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces hunger signals and improves blood sugar control, helping patients lose an average of 15-22% of body weight in clinical trials
Impact on Heart Rate and Rhythm Semaglutide is a medication primarily used to treat type 2 diabetes and aid in weight loss
Early data are limited but interesting
US$ 25.38
US$ 23.80
US$ 27.85
US$ 28.57
US$ 27.81
US$ 23.50
US$ 29.20
